Jean Isherwood
Obstetrics & Gynecology · Lexington, SCNPI 1104812403
Payments from drug & device makers
Across 70 payments — averaging $91.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$5K
- Avion Pharmaceuticals$220
- Exeltis, USA Inc.$160
- AbbVie$95
- Myovant Sciences Inc.$88
- Johnson & Johnson$75
- plus $540 from 14 others
What the payments were for
- Consulting fees$3,48654%
- Travel & lodging$95515%
- Food & beverage$1,90730%
- Education$911%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 18 | $5,261 |
| Avion Pharmaceuticals | 1 | $220 |
| Exeltis, USA Inc. | 10 | $160 |
| AbbVie | 6 | $95 |
| Myovant Sciences Inc. | 1 | $88 |
| Johnson & Johnson | 2 | $75 |
| Therapeuticsmd, Inc. | 4 | $73 |
| Dexcom, Inc. | 2 | $63 |
| Daiichi Sankyo Inc. | 3 | $58 |
| Organon | 8 | $55 |
| Pfizer | 2 | $54 |
| Medtronic | 1 | $50 |
| Bayer | 3 | $49 |
| Exact Sciences | 3 | $43 |
| Sage Therapeutics, LLC | 1 | $20 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $19 |
| Boston Scientific | 1 | $19 |
| Astellas Pharma Global Development | 1 | $15 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
| Aspira Women's Health Inc | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,439 in reported general payments places this provider in the 90th percentile of 673 obstetrics & gynecology providers in South Carolina.
See all obstetrics & gynecology providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 49 | $2,154 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 14 | $227 |
| Alendronate Sodium | 12 | $108 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Lexington
- Christopher JenningsAnderson$1.3M
- George HelmrichGreenville$1.2M
- Meghan HillColumbia$795K
- Patricia ThompsonBeaufort$649K
- Ronnie GivensSummerville$640K
- Helena KirkpatrickMyrtle Beach$527K
- Heather SchwartzbergSummerville$320K
- David GodwinGreenville$261K
- William ColemanGreenville$242K
- Melvin SeidMauldin$235K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.